tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
RCUS is currently covered by 7 analysts with an average price target of $39.8. This is a potential upside of $19.77 (98.7%) from yesterday's end of day stock price of $20.03.
Arcus Biosciences's activity chart (see below) currently has 124 price targets and 108 ratings on display. The stock rating distribution of RCUS is 64.71% BUY and 35.29% HOLD.
Analysts average stock forecasts to be materialized ratio is 40.12% with an average time for these price targets to be met of 234.13 days.
Highest price target for RCUS is $56, Lowest price target is $14, average price target is $29.86.
Most recent stock forecast was given by SALVEEN RICHTER from GOLDMAN SACHS on 13-Jan-2026. First documented stock forecast 09-Apr-2018.
Currently out of the existing stock ratings of RCUS, 11 are a BUY (64.71%), 6 are a HOLD (35.29%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Apr-2018
$28
$6.96 (33.08%)
$16
23 days ago
(13-Jan-2026)
2/5 (40%)
$6.7 (31.46%)
420
Buy Since 11-Oct-2022
$20
$-1.04 (-4.94%)
$22
28 days ago
(08-Jan-2026)
3/9 (33.33%)
$-3.2 (-13.79%)
248
Buy Since 26-Feb-2025
$32
$10.96 (52.09%)
$28
1 months 24 days ago
(12-Dec-2025)
4/6 (66.67%)
$6.86 (27.29%)
312
Hold Since 18-Nov-2022
$26
$4.96 (23.57%)
$17
2 months 8 days ago
(28-Nov-2025)
5/5 (100%)
$0.44 (1.72%)
218
Buy Since 24-May-2019
$56
$34.96 (166.16%)
$54
3 months 7 days ago
(29-Oct-2025)
2/13 (15.38%)
$35.71 (176.00%)
294
What is RCUS (Arcus Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on RCUS (Arcus Biosciences) with a proven track record?
Which analyst has the most public recommendations on RCUS (Arcus Biosciences)?
Which analyst is the currently most bullish on RCUS (Arcus Biosciences)?
Which analyst is the currently most reserved on RCUS (Arcus Biosciences)?
